By Turna Ray

This article has been updated to clarify comments made by Scientia Advisors' Patrick Terry.

BETHESDA, Md. — As far as XDx is concerned, it has jumped through all the right hoops to show the clinical utility of its AlloMap genomic heart transplant rejection test. But according to a company official, it hasn't seen the level of adoption it expected for the test because doctors don't have a monetary incentive to use it in place of cardiac biopsies.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.

New Mexico is re-doing its proposed science education standards after criticism, the Associated Press reports.

Agbio executives say gene editing will speed up breeding efforts, according to the Wall Street Journal.

La Trobe University's Jenny Graves has won the $250,000 Prime Minister's Prize for Science, the Guardian reports.

In Cell this week: post-treatment changes to melanoma genome, multi-omics analysis of muscle-invasive bladder cancer, and more.